QVCGP Q3 2025 Earnings Significant Loss Per Common Share Reported Preferred Stock Unchanged HAE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Rally Cytokinetics CYTK Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Progress Continues DDL Q4 2025 Earnings Profitability Highlight as EPS Reported at 041 MDCX Q1 2026 Earnings WiderthanExpected Losses as Stock Rises 548